Lawmakers call for 'morning-after' pill approval

Catch up with NBC News Clone on today's hot topic: Wbna9665636 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.

A bipartisan group of 62 U.S. lawmakers have called on the new acting head of the Food and Drug Administration to allow sales of Barr Pharmaceuticals Inc.’s “morning-after” pill without a prescription, according to a letter made public Tuesday.

A bipartisan group of 62 U.S. lawmakers have called on the new acting head of the Food and Drug Administration to allow sales of Barr Pharmaceuticals Inc.’s “morning-after” pill without a prescription, according to a letter made public Tuesday.

In a letter to Acting FDA Commissioner Dr. Andrew von Eschenbach, the members of Congress stopped short of accusing the agency of earlier postponing a ruling because of politics, but chided officials for ignoring evidence.

“We believe this new delay does not truly reflect valid scientific or regulatory concerns,” they wrote in a letter dated Oct. 7.

Barr has pursued over-the-counter sales of its emergency contraceptive drug, called Plan B, for more than two years.

The drug contains higher levels of a hormone used in birth control pills and must be taken within 72 hours of sexual intercourse. It was approved as a prescription in 1999.

An FDA advisory panel overwhelmingly supported nonprescription sales, but early last year the FDA rejected Barr’s proposal citing concerns about use among teen-aged girls younger than 16. The drug maker refiled its bid, proposing over-the-counter sales for those 16 and older.

In August, the FDA announced an indefinite delay over the issue. Agency officials said the drug was safe and effective, but that they were unsure how to regulate a restriction based on age.

“We find it contradictory and disconcerting that the FDA’s concerns are a direct result of the agency’s own recommendations last May,” the lawmakers, which included six Republicans and one Independent, wrote.

Religious conservatives and other opponents say easier access to emergency contraceptive will spur promiscuity and sexually transmitted diseases. Supporters, including most doctors and women’s rights groups, say it will prevent unwanted pregnancies and abortions.

“By further delaying the FDA’s decision to expand access to EC (emergency contraception), you are seriously hindering efforts to reduce abortions across the U.S.,” the lawmakers, said, calling on von Eschenbach to approve Plan B “without further delay.”

×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone